Bildkälla: Stockfoto

Abliva: Q2’21: KL1333 Project Progressing - Redeye

Redeye is encouraged by the progress of KL1333 ahead of an expected major capital raise to fund the next pivotal step in clinical development.

Redeye is encouraged by the progress of KL1333 ahead of an expected major capital raise to fund the next pivotal step in clinical development.
Börsvärldens nyhetsbrev
ANNONSER